| Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines. | |
| | |
MedLine Citation:
|
PMID: 1667418 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The antihelminthic drug suramin inhibits the binding of monoradioiodinated VIP (125I-VIP) to two human cancerous cell lines, namely HT 29-D4 and IGR 39 derived from a colic adenocarcinoma and a superficial melanoma respectively, with an IC50 of 280 micrograms/ml. The drug is not able to remove 125I-VIP previously bound to either types of cells even with concentration as high as 1500 micrograms/ml. Neither 125I-VIP binding nor VIP binding sites molecular weight are affected by pretreatment of the cells by the drug. Suramin at 1000 micrograms/ml inhibits by 56% to 99% the cAMP accumulation induced by VIP, depending on the VIP concentrations and the cell lines used for the experiments. On the contrary the drug does not have any effects on the cAMP accumulation induced by the beta receptor agonist isoproterenol. Also suramin does not affect the basal accumulation of cAMP in both types of cells either in acute or chronic treatment with the drug. We speculate that these observations may account, at least in part, for the in vivo and in vitro effects of VIP and suramin on cell proliferation and survival. |
| | |
Authors:
|
C Bellan; P Pic; J Marvaldi; J Fantini; J Pichon |
Related Documents
:
|
9718138 - The efficacy of nucleoside analogs against jc virus multiplication in a persistently in... 15627058 - Effects of mechanochemically activated doxorubicin and 40 mhz frequency irradiation on ... 21607048 - Design and evaluation of self-nanoemulsifying drug delivery system of flutamide. 7138568 - The effect of alkylating agents and other drugs on the accumulation of melphalan by mur... 19088498 - Influence of ethanol on the solubility, ionization and permeation characteristics of ib... 1695298 - Multicenter study with isradipine and diuretics against atherosclerosis. us midas resea... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Second messengers and phosphoproteins Volume: 13 ISSN: 0895-7479 ISO Abbreviation: Second Messengers Phosphoproteins Publication Date: 1991 |
Date Detail:
|
Created Date: 1992-06-10 Completed Date: 1992-06-10 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9002049 Medline TA: Second Messengers Phosphoproteins Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 163-71 Citation Subset: IM |
Affiliation:
|
Institut de Chimie Biologique, CNRS URA 202, Université D'Aix-Marseille I, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cross-Linking Reagents Cyclic AMP / metabolism* Humans Iodine Radioisotopes / diagnostic use Isoproterenol / pharmacology Protein Binding Receptors, Gastrointestinal Hormone / chemistry Receptors, Vasoactive Intestinal Peptide Succinimides Suramin / pharmacology* Tumor Cells, Cultured Vasoactive Intestinal Peptide / metabolism, pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Cross-Linking Reagents; 0/Iodine Radioisotopes; 0/Receptors, Gastrointestinal Hormone; 0/Receptors, Vasoactive Intestinal Peptide; 0/Succinimides; 145-63-1/Suramin; 37221-79-7/Vasoactive Intestinal Peptide; 60-92-4/Cyclic AMP; 76403-92-4/disuccinimidyl suberate; 7683-59-2/Isoproterenol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of two volatile anesthetics and a volatile convulsant on the excitatory and inhibitory amino...
Next Document: Transient activation of calcineurin during thiol modification.